nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Hypokalaemia—Vandetanib—thyroid cancer	0.0225	0.0225	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Vandetanib—thyroid cancer	0.02	0.02	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Vandetanib—thyroid cancer	0.0192	0.0192	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Vandetanib—thyroid cancer	0.019	0.019	CcSEcCtD
Ceftaroline fosamil—Infestation—Vandetanib—thyroid cancer	0.019	0.019	CcSEcCtD
Ceftaroline fosamil—Renal failure—Vandetanib—thyroid cancer	0.0187	0.0187	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Vandetanib—thyroid cancer	0.018	0.018	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Vandetanib—thyroid cancer	0.0174	0.0174	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Vandetanib—thyroid cancer	0.0167	0.0167	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Vandetanib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Sorafenib—thyroid cancer	0.0152	0.0152	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Vandetanib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Epirubicin—thyroid cancer	0.0139	0.0139	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Sorafenib—thyroid cancer	0.0135	0.0135	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Doxorubicin—thyroid cancer	0.0129	0.0129	CcSEcCtD
Ceftaroline fosamil—Convulsion—Vandetanib—thyroid cancer	0.0129	0.0129	CcSEcCtD
Ceftaroline fosamil—Infestation—Sorafenib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Sorafenib—thyroid cancer	0.0128	0.0128	CcSEcCtD
Ceftaroline fosamil—Renal failure—Sorafenib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Sorafenib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Vandetanib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Sorafenib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Sorafenib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Pain—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Constipation—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Ceftaroline fosamil—Erythema—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00992	0.00992	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vandetanib—thyroid cancer	0.00959	0.00959	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Vandetanib—thyroid cancer	0.00959	0.00959	CcSEcCtD
Ceftaroline fosamil—Anaemia—Sorafenib—thyroid cancer	0.00927	0.00927	CcSEcCtD
Ceftaroline fosamil—Pruritus—Vandetanib—thyroid cancer	0.00858	0.00858	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00848	0.00848	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Epirubicin—thyroid cancer	0.00833	0.00833	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vandetanib—thyroid cancer	0.0083	0.0083	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Sorafenib—thyroid cancer	0.00819	0.00819	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Sorafenib—thyroid cancer	0.00803	0.00803	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vandetanib—thyroid cancer	0.00802	0.00802	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Sorafenib—thyroid cancer	0.00801	0.00801	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Sorafenib—thyroid cancer	0.00795	0.00795	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vandetanib—thyroid cancer	0.00772	0.00772	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00771	0.00771	CcSEcCtD
Ceftaroline fosamil—Rash—Vandetanib—thyroid cancer	0.00765	0.00765	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vandetanib—thyroid cancer	0.00764	0.00764	CcSEcCtD
Ceftaroline fosamil—Headache—Vandetanib—thyroid cancer	0.0076	0.0076	CcSEcCtD
Ceftaroline fosamil—Nausea—Vandetanib—thyroid cancer	0.00721	0.00721	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Epirubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00707	0.00707	CcSEcCtD
Ceftaroline fosamil—Constipation—Sorafenib—thyroid cancer	0.007	0.007	CcSEcCtD
Ceftaroline fosamil—Pain—Sorafenib—thyroid cancer	0.007	0.007	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—thyroid cancer	0.00661	0.00661	CcSEcCtD
Ceftaroline fosamil—Urticaria—Sorafenib—thyroid cancer	0.0065	0.0065	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Sorafenib—thyroid cancer	0.00647	0.00647	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Sorafenib—thyroid cancer	0.00647	0.00647	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Sorafenib—thyroid cancer	0.00603	0.00603	CcSEcCtD
Ceftaroline fosamil—Pruritus—Sorafenib—thyroid cancer	0.00579	0.00579	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Epirubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Sorafenib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Ceftaroline fosamil—Dizziness—Sorafenib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—thyroid cancer	0.00527	0.00527	CcSEcCtD
Ceftaroline fosamil—Vomiting—Sorafenib—thyroid cancer	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Ceftaroline fosamil—Rash—Sorafenib—thyroid cancer	0.00516	0.00516	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Sorafenib—thyroid cancer	0.00516	0.00516	CcSEcCtD
Ceftaroline fosamil—Headache—Sorafenib—thyroid cancer	0.00513	0.00513	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—thyroid cancer	0.00497	0.00497	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—thyroid cancer	0.00487	0.00487	CcSEcCtD
Ceftaroline fosamil—Nausea—Sorafenib—thyroid cancer	0.00486	0.00486	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—thyroid cancer	0.0048	0.0048	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—thyroid cancer	0.00466	0.00466	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00449	0.00449	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00444	0.00444	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—thyroid cancer	0.00417	0.00417	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00415	0.00415	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00389	0.00389	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—thyroid cancer	0.00385	0.00385	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—thyroid cancer	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00313	0.00313	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—thyroid cancer	0.00297	0.00297	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—thyroid cancer	0.00294	0.00294	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
